Abstract
Genome-wide association studies have identified common variants in transcription factor 4 (TCF4) as susceptibility loci for schizophrenia, Fuchs' endothelial corneal dystrophy, and primary sclerosing cholangitis. By contrast, rare TCF4 mutations cause Pitt-Hopkins syndrome, a disorder characterized by intellectual disability and developmental delay, and have also been described in patients with other neurodevelopmental disorders. TCF4 therefore sits at the nexus between common and rare disorders. TCF4 interacts with other basic helix-loop-helix proteins, forming transcriptional networks that regulate the differentiation of several distinct cell types. Here, we review the role of TCF4 in these seemingly diverse disorders and discuss recent data implicating TCF4 as an important regulator of neurodevelopment and epithelial-mesenchymal transition.
Original language | English (US) |
---|---|
Pages (from-to) | 322-331 |
Number of pages | 10 |
Journal | Trends in Molecular Medicine |
Volume | 20 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2014 |
Funding
This work was funded by a Medical Research Council (MRC) studentship (M.P.F.) and an MRC Centenary Award (D.J.B., M.P.F.).
Keywords
- Epithelial-mesenchymal transition
- Fuchs' endothelial corneal dystrophy
- Intellectual disability
- Pitt-Hopkins syndrome
- Schizophrenia
- Transcription
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology